Association of SGLT-2 Inhibitor Use with Wound Healing and Amputation Risk in Patients with Diabetic Foot Ulcers: A Prospective Observational Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Aim: The extant literature contains conflicting findings with regard to the safety of Sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitors) in patients with diabetic foot ulcers (DFUs). The present study aims to evaluate the association between the use of SGLT-2 inhibitors and wound healing outcomes and the risk of amputation in patients diagnosed with type 2 diabetes mellitus (DM) and Wagner stage 1-2 DFU. Methods: This prospective observational study was conducted between March 1, 2023, and August 31, 2024. The study population comprised 208 patients with type 2 DM and Wagner stage 1-2 DFU, all of whom completed six months of follow-up. Patients were grouped according to treatment: metformin plus insulin (n=102) or metformin plus insulin and an SGLT-2 inhibitor (n=106). Clinical, biochemical, wound-healing, and amputation outcomes were compared between groups. Subgroup analyses were performed for users of dapagliflozin and empagliflozin. Associations of SGLT-2 inhibitor use with wound healing and amputation were assessed using ordinal and binary logistic regression, respectively, with multivariable adjustment for relevant baseline differences. Results: No statistically significant differences in wound healing and amputation rates were observed between patients with and without SGLT-2 inhibitor use. In the SGLT-2 inhibitor group, levels of serum albumin were elevated, whereas urinary albumin excretion was reduced (p=0.002 and p<0.001, respectively). No significant differences were observed between patients treated with dapagliflozin and empagliflozin in terms of wound healing or amputation. Conclusion: No clear association has been observed between the use of SGLT-2 inhibitors and impaired wound healing or amputation in patients with DFUs. Further studies with larger sample sizes are needed to clarify these findings.
Source: Medical Bulletin of Haseki
Institutions: Cukurova University, Sağlık Bilimleri Üniversitesi
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7234838487
